C1(C)C=CC(S(CC[O:12][C:13](=[O:49])[C:14]2[CH:19]=[CH:18][C:17]([CH3:20])=[C:16]([S:21]([N:24]3[C:28]4[CH:29]=[CH:30][CH:31]=[CH:32][C:27]=4[N:26]=[C:25]3[S:33]([CH2:35][C:36]3[C:41]([CH3:42])=[C:40]([O:43][CH2:44][CH2:45][CH2:46][O:47][CH3:48])[CH:39]=[CH:38][N:37]=3)=[O:34])(=[O:23])=[O:22])[CH:15]=2)(=O)=O)=CC=1.C([O-])(O)=O.[Na+:55]>CC#N.O>[Na+:55].[CH3:48][O:47][CH2:46][CH2:45][CH2:44][O:43][C:40]1[CH:39]=[CH:38][N:37]=[C:36]([CH2:35][S:33]([C:25]2[N:24]([S:21]([C:16]3[CH:15]=[C:14]([CH:19]=[CH:18][C:17]=3[CH3:20])[C:13]([O-:49])=[O:12])(=[O:23])=[O:22])[C:28]3[CH:29]=[CH:30][CH:31]=[CH:32][C:27]=3[N:26]=2)=[O:34])[C:41]=1[CH3:42]To the solution of 3-{2-[4-(3-methoxy-propoxy)-3-methyl-pyridin-2-yl-methanesulfinyl]-benzimidazole-1-sulfonyl}-4-methylbenzoic acid 2-(toluene-4-sulfonyl)ethyl ester (Intermediate 53, 1.5 g, 1.97 mmol) in 15 mL of CH3CN was added a solution of NaHCO3 (200 mg, 2.36 mmol, 1.2 eq) in 7 mL of H2O at room temperature, and then the mixture was heated to 65° C. for 2 h. Thereafter most of the CH3CN was removed, the mixture was extracted with EtOAc, and the aqueous layer was lyophilized overnight. The solid was dissolved in CH2Cl2, and then the mixture was filtered to remove insoluble solids. The filtrate was concentrated to near dryness. The residual oil was dissolved in about 2 mL of CH2Cl2 and EtOAc-hexane (7:1) was added to precipitate a white solid. The precipitate was collected by filtration, washed with EtOAc-hexane (7:1), and dried under vacuum to give 950 mg (80%) of 3-{2-[4-(3-methoxy-propoxy)-3-methyl-pyridin-2-yl-methanesulfinyl]-benzimidazole-1-sulfonyl}-4-methylbenzoic acid sodium salt (Compound 28) as a white solid.